These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 29587180)

  • 1. Prioritization of potential drug targets against P. aeruginosa by core proteomic analysis using computational subtractive genomics and Protein-Protein interaction network.
    Uddin R; Jamil F
    Comput Biol Chem; 2018 Jun; 74():115-122. PubMed ID: 29587180
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Core Proteomic Analysis of Unique Metabolic Pathways of Salmonella enterica for the Identification of Potential Drug Targets.
    Uddin R; Sufian M
    PLoS One; 2016; 11(1):e0146796. PubMed ID: 26799565
    [TBL] [Abstract][Full Text] [Related]  

  • 3. From Proteome to Potential Drugs: Integration of Subtractive Proteomics and Ensemble Docking for Drug Repurposing against
    Urra G; Valdés-Muñoz E; Suardiaz R; Hernández-Rodríguez EW; Palma JM; Ríos-Rozas SE; Flores-Morales CA; Alegría-Arcos M; Yáñez O; Morales-Quintana L; D'Afonseca V; Bustos D
    Int J Mol Sci; 2024 Jul; 25(15):. PubMed ID: 39125594
    [No Abstract]   [Full Text] [Related]  

  • 4. In-silico Subtractive Proteomic Analysis Approach for Therapeutic Targets in MDR Salmonella enterica subsp. enterica serovar Typhi str. CT18.
    Rahman N; Muhammad I; Nayab GE; Khan H; Filosa R; Xiao J; Hassan STS
    Curr Top Med Chem; 2019; 19(29):2708-2717. PubMed ID: 31702501
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Design, synthesis, and evaluation of pyrazolo-pyrazole derivatives on Methylisocitratelyase of Pseudomonas aeruginosa: in silico and in vitro study.
    Pulaganti M; C M A; Kumar CS
    J Biomol Struct Dyn; 2017 Aug; 35(11):2509-2529. PubMed ID: 27686121
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Proteomic analysis of the sarcosine-insoluble outer membrane fraction of Pseudomonas aeruginosa responding to ampicilin, kanamycin, and tetracycline resistance.
    Peng X; Xu C; Ren H; Lin X; Wu L; Wang S
    J Proteome Res; 2005; 4(6):2257-65. PubMed ID: 16335974
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Predicting drug targets by homology modelling of Pseudomonas aeruginosa proteins of unknown function.
    Babic N; Kovacic F
    PLoS One; 2021; 16(10):e0258385. PubMed ID: 34648550
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prioritization of potential vaccine targets using comparative proteomics and designing of the chimeric multi-epitope vaccine against Pseudomonas aeruginosa.
    Solanki V; Tiwari M; Tiwari V
    Sci Rep; 2019 Mar; 9(1):5240. PubMed ID: 30918289
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genotypic and phenotypic analyses of a Pseudomonas aeruginosa chronic bronchiectasis isolate reveal differences from cystic fibrosis and laboratory strains.
    Varga JJ; Barbier M; Mulet X; Bielecki P; Bartell JA; Owings JP; Martinez-Ramos I; Hittle LE; Davis MR; Damron FH; Liechti GW; Puchałka J; dos Santos VA; Ernst RK; Papin JA; Albertí S; Oliver A; Goldberg JB
    BMC Genomics; 2015 Oct; 16():883. PubMed ID: 26519161
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cross-regulatory network in Pseudomonas aeruginosa biofilm genes and TiO
    Anupama R; Sajitha Lulu S; Mukherjee A; Babu S
    Gene; 2018 Mar; 647():289-296. PubMed ID: 29337088
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of putative drug targets in Vancomycin-resistant Staphylococcus aureus (VRSA) using computer aided protein data analysis.
    Hasan MA; Khan MA; Sharmin T; Hasan Mazumder MH; Chowdhury AS
    Gene; 2016 Jan; 575(1):132-43. PubMed ID: 26319513
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification and characterization of potential drug targets by subtractive genome analyses of methicillin resistant Staphylococcus aureus.
    Uddin R; Saeed K
    Comput Biol Chem; 2014 Feb; 48():55-63. PubMed ID: 24361957
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Target identification in Fusobacterium nucleatum by subtractive genomics approach and enrichment analysis of host-pathogen protein-protein interactions.
    Kumar A; Thotakura PL; Tiwary BK; Krishna R
    BMC Microbiol; 2016 May; 16():84. PubMed ID: 27176600
    [TBL] [Abstract][Full Text] [Related]  

  • 14. To Hit or Not to Hit, That Is the Question - Genome-wide Structure-Based Druggability Predictions for Pseudomonas aeruginosa Proteins.
    Sarkar A; Brenk R
    PLoS One; 2015; 10(9):e0137279. PubMed ID: 26360059
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Insights into mechanisms and proteomic characterisation of Pseudomonas aeruginosa adaptation to a novel antimicrobial substance.
    Cierniak P; Jübner M; Müller S; Bender K
    PLoS One; 2013; 8(7):e66862. PubMed ID: 23869205
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Conessine as a novel inhibitor of multidrug efflux pump systems in Pseudomonas aeruginosa.
    Siriyong T; Srimanote P; Chusri S; Yingyongnarongkul BE; Suaisom C; Tipmanee V; Voravuthikunchai SP
    BMC Complement Altern Med; 2017 Aug; 17(1):405. PubMed ID: 28806947
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A Novel indole compound that inhibits Pseudomonas aeruginosa growth by targeting MreB is a substrate for MexAB-OprM.
    Robertson GT; Doyle TB; Du Q; Duncan L; Mdluli KE; Lynch AS
    J Bacteriol; 2007 Oct; 189(19):6870-81. PubMed ID: 17644596
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Determinants of Antibacterial Spectrum and Resistance Potential of the Elongation Factor G Inhibitor Argyrin B in Key Gram-Negative Pathogens.
    Jones AK; Woods AL; Takeoka KT; Shen X; Wei JR; Caughlan RE; Dean CR
    Antimicrob Agents Chemother; 2017 Apr; 61(4):. PubMed ID: 28096160
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Core Proteome of Biofilm-Grown Clinical
    Erdmann J; Thöming JG; Pohl S; Pich A; Lenz C; Häussler S
    Cells; 2019 Sep; 8(10):. PubMed ID: 31547513
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Proteomic characterization of Pseudomonas aeruginosa PAO1 inner membrane.
    Casabona MG; Vandenbrouck Y; Attree I; Couté Y
    Proteomics; 2013 Aug; 13(16):2419-23. PubMed ID: 23744604
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.